Entrance to Pfizer headquarters
|
|
Public | |
Traded as | |
Industry | Pharmaceutical |
Founded | 1849 |
Founders |
Charles Pfizer Charles F. Erhart |
Headquarters | New York City, United States |
Area served
|
Worldwide |
Key people
|
Ian Read (Chairman & CEO) |
Products | See list |
Revenue | US$48.85 billion (2015) |
US$11.05 billion (2015) | |
US$7.74 billion (2015) | |
Total assets | US$169.3 billion (2015) |
Total equity | US$71.30 billion (2015) |
Number of employees
|
78,300 (2015) |
Subsidiaries | Agouron Pharmaceuticals G.D. Searle Greenstone Hospira InnoPharma Parke-Davis Pfizer UK |
Website | www |
Pfizer Inc. /ˈfaɪzər/ is an American global pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. It is among the world's largest pharmaceutical companies. Pfizer is listed on the , and its shares have been a component of the Dow Jones Industrial Average since 2004.
Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer's products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin) for neuropathic pain/fibromyalgia; Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and Celebrex/Celebra (celecoxib), an anti-inflammatory drug.
Pfizer was founded in 1849 by cousins Charles Pfizer and Charles F. Erhart in New York City as a manufacturer of fine chemicals. Its discovery of Terramycin (oxytetracycline) in 1950 put it on a path towards becoming a research-based pharmaceutical company. Pfizer has made numerous acquisitions, including Warner–Lambert in 2000, Pharmacia in 2003, and Wyeth in 2009 (the largest of the three at $68 billion).